2-semestre 2025

Bonjour à tous,
Vous trouverez ci-dessous les titres des publications des membres du réseau ENDOCAN TUTHYREF.
Félicitations aux auteurs!

Retrouvez les publications dans :   Espace membre

2^ème sem 2025 

Requête:

(RAHIM A[Author] OR ALGHUZLAN A[Author] OR BARDET S[Author] OR BARGE ML[Author] OR BATISSE-LIGNIER M[Author] OR BENISVY D[Author] OR BORSON-CHAZOT F[Author] OR Calcagno F[Author] OR BUFFET C[Author] OR Lussey-Lepoutre C[Author] OR Chevalier B[Author] OR CHOUGNET C[Author] OR Sajous C[Author] OR CIAPPUCCINI R[Author] OR Cogne M[Author] OR CRINIERE L[Author] OR CUNY T[Author] OR De la Fouchardière C[Author] OR DESAILLOUD R[Author] OR DO CAO C[Author] OR DRUI D[Author] OR DRUTEL A[Author] OR DYGAI-COCHET I[Author] OR EDET-SANSON A[Author] OR Gilly O[Author] OR GODBERT Y[Author] OR GROUSSIN L[Author] OR GRUNENWALD S[Author] OR Lasolle H[Author] OR HESCOT S[Author] OR ILLOUZ F[Author] OR Borget I[Author] OR JANNIN A[Author] OR KARABAJAKIAN A[Author] OR KELLY A[Author] OR LABOUREAU S[Author] OR LAMBERT A[Author] OR LAMARTINA L[Author] OR Haissaguerre M[Author] OR MULLER M[Author] OR NARCISO B[Author] OR Pinochet P[Author] OR Raymond P[Author] OR RODIEN P[Author] OR ROUDAUT N[Author] OR SALAS S[Author] OR SCHNEEGANS O[Author] OR SCHVARTZ C[Author] OR Castellnou S[Author] OR VELAYOUDOM-CEPHISE FL[Author] OR VERA P[Author] OR ZALZALI M[Author] OR ZANETTA S[Author] OR ZERDOUD S[Author] OR HADOUX J[Author] OR Nascimento C[Author] OR Eberle MC[Author] OR CATARGI B[Author] OR CHABRE O[Author] OR KLEIN M[Author] OR LEENHARDT L[Author] OR NICOLLI P[Author] OR TAIEB D[Author] OR RUSU D[Author] OR Schlumberger M[Author] OR Leboulleux S[Author] OR TUTHYREF OR ENDOCAN-RENATEN) AND ("thyroid neoplasms"[Mesh] OR (("Thyroid"[tw] OR "Thyroid Gland"[Mesh]) AND ("Neoplasms"[Mesh] OR "neoplas*"[tw] OR "tumor*"[tw] OR "tumour*"[tw] OR "cancer*"[tw] OR "lymphoma*"[tw] OR "malignan*"[tw] OR "oncolog*"[tw] OR "carcinom*"[tw] OR "adenoma*"[tw] OR "TUTHYREF" OR "ENDOCAN-RENATEN"))) AND ((2025/03/04 [edat]: 2025/07/04[edat]) OR (2025/03/04 [epdat]: 2025/07/04 [epdat]) OR (2025/03/04 [dp]: 2025/07/04 [dp]))

Résultat :

1. Ansart F, de Ponthaud C, Buffet C, Menegaux F, Gaujoux S, Chereau N. One- or Two-Step Total Thyroidectomy for Cancer Indications: A 20-Year Retrospective Study from a Referral Center. Ann Surg Oncol. 2025 Apr;32(4):2329-2334. doi: 1245/s10434-024-16707-6. Epub 2024 Dec 29. PMID: 39739263. Voir fichier : Ansart2025-Total-Thyroidectomy.pdf
   
2. Berrandou TE, Cordina-Duverger E, Mulot C, Guizard AV, Schvartz C, Laurent- Puig P, Zidane M, De Vathaire F, Guénel P, Truong T. Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer. Front Genet. 2025 Jun 4;16:1539090. doi: 10.3389/fgene.2025.1539090. PMID: 40534841; PMCID: Voir fichier : Berrandou2025- Polymorphisms.pdf
   
   
3. Bischoff H, Fattori A, Moinard-Butot F, Schneegans O, Diaz P, Reita D, Rimelen V, Voegeli AC, Bender L. First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib. Thyroid. 2025 Jun;35(6):701-705. doi: 10.1089/thy.2025.0017. Epub 2025 May 16. PMID: 40376737. Voir fichier : Bischoff2025-ALK-Fusion.pdf
   
   
4. Do Cao C, Godbert Y, Bardet S, Borson-Chazot F, Decaussin-Petrucci M, Wassermann J, Lugat A, Nascimento C, Leboulleux S, Narciso B, Jannin A, Hadoux J, Schwartz P, Hescot S, Buffet C, Lamartina L; ENDOCAN-TUTHYREF network. ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular- derived thyroid cancer. Ann Endocrinol (Paris). 2025 Jul;86(4):101735. doi: 1016/j.ando.2025.101735. Epub 2025 May 7. PMID: 40345488. Voir fichier : DoCao2025-Refractory-follicular.pdf
   
   
5. Garnier S, Mahéo C, Potard G, Cavarec MB, Roudaut N, Thuillier P, Marianowski R, Abgral R, Leclere JC. Contribution of 18 F-fluorocholine PET-CT to the preoperative localisation of parathyroid adenoma for the treatment of primary Sci Rep. 2025 Mar 23;15(1):10018. doi: 10.1038/s41598-025-94735-2. PMID: 40122914; PMCID: PMC11930921. Voir fichier : Garnier2025- Contribution-of-18F.pdf
   
   
6. Haissaguerre M, Groussin L, Lamartina L, Buffet C, Caron P. Key data from the 2024 European Thyroid Association annual meeting: Differentiated thyroid What's new in low-risk thyroid carcinoma? Update after the 2024 ETA congress. Ann Endocrinol (Paris). 2025 Apr;86(2):101707. doi: 10.1016/j.ando.2025.101707. Epub 2025 Feb 3. PMID: 39909103. Voir fichier : Haissaguerre2025- Differentiated-thyroid-carcinoma.pdf
   
   
7. Hartl DM, Bani MA, Ghuzlan AA, Simonescu AE, Breuskin I, Marhic A, Albiges L, Lamartina L, Hadoux J. Case Report: Locally invasive thyroid metastases from renal cell carcinoma: surgery after neoadjuvant therapy. Front Oncol. 2025 May 28;15:1543060. doi: 10.3389/fonc.2025.1543060. PMID: 40502628; PMCID: Voir fichier : Hartl2025-Locally-invasive.pdf
   
   
8. Jannin A, Escande A, Hartl D, Louvel G, Breuskin I, Borson-Chazot F, Hadoux J, Lamartina L, Do Cao C, Deschamps F. ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer. Ann Endocrinol (Paris). 2025 Jul;86(4):101790. doi: 10.1016/j.ando.2025.101790. Epub 2025 May PMID: 40379205. Voir fichier : Jannin2025-Locoregionaltherapies.pdf
   
   
9. Lamartina L, Hadoux J, Borson-Chazot F, Do Cao C. ENDOCAN TUTHYREF network consensus recommendations for refractory thyroid cancer management. Ann Endocrinol (Paris). 2025 Jul;86(4):101732. doi: 10.1016/j.ando.2025.101732. Epub 2025 Apr 25. PMID: 40288438. Voir fichier : Lamartina2025-refractory-thyroid.pdf
   
   
10. Lamartina L, Jannin A, Decaussin-Petrucci M, Bardet S, Escande A, Ciappuccini R, Borson Chazot F, Al Ghuzlan A, Do Cao C, Hadoux J. ENDOCAN TUTHYREF network consensus recommendations: Anaplastic thyroid cancer. Ann Endocrinol (Paris). 2025 Jul;86(4):101788. doi: 10.1016/j.ando.2025.101788. Epub 2025 May 9. PMID: 40350149. Voir fichier : Lamartina2025-Anaplastic-thyroid.pdf
    
    
11. Lasolle H, Do Cao C, Lamartina L, Al Ghuzlan A, Drui D, Buffet C, Leboulleux S, Hescot S, Godbert Y, Zerdoud S, Ciappuccini R, Jannin A, Hadoux J, Borson- Chazot F. ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer. Ann Endocrinol (Paris). 2025 Jul;86(4):101733. doi: 1016/j.ando.2025.101733. Epub 2025 Apr 25. PMID: 40288439. Voir fichier : Lasolle2025-Refractory-medullary.pdf
    
    
12. Leboulleux S, Boucai L, Busaidy N, Durante C, Fagin JA, Fazeli S, Gianoukakis AG, Haugen BR, Kang H, Konda B, Laetsch TW, Locati L, Ryder M, Spitzweg C, Worden FP, Wirth L, Ho A. Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement. Lancet Diabetes Endocrinol. 2025 Jun;13(6):516-527. doi: 10.1016/S2213-8587(25)00064-6. Epub 2025 Apr 30. PMID: Voir fichier : Leboulleux2025-Redifferentiation.pdf
    
    
13. Luzuy-Guarnero V, Jarlborg P, Demarchi MS, Mavromati M, De Vito C, Saiji E, Bianchetto Wolf N, Leboulleux S, Triponez F. Prise en charge du cancer thyroïdien de souche folliculaire en 2025 [Management of follicular cell-derived thyroid cancer in 2025]. Rev Med Suisse. 2025 Jun 11;21(922):1210-1215. French. doi: 10.53738/REVMED.2025.21.922.47328. PMID: 40509717. Voir fichier : Luzuy-Guarnero2025-souche-folliculaire.pdf
    
    
14. Roy M, Ghander C, Bigorgne C, Brière M, Deniziaut G, Ansart F, Lussey- Lepoutre C, Buffet C. An update on management of cytologically indeterminate thyroid nodules. Ann Endocrinol (Paris). 2025 Apr;86(2):101711. doi: 1016/j.ando.2025.101711. Epub 2025 Feb 15. PMID: 39961482. Voir fichier : roy2025- cytologically.pdf
    
    
15. Ryška A, Capdevila J, Dettmer MS, Elisei R, Führer D, Hadoux J, Jarzab B, Locati LD, Newbold K, Tallini G, Uccella S, Wirth L, Singh R, Simon IM, Camacho P, Fugazzola L. Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus. Eur Thyroid J. 2025 Jun 18:ETJ-25-0024. doi: 1530/ETJ-25-0024. Epub ahead of print. PMID: 40540622. Voir fichier : Ryska2025-molecular.pdf
    
    
16. Schubert L, Haissaguerre M, Caron P, Groussin L. Key data from the 2024 European Thyroid Association annual congress: What's new in aggressive thyroid carcinoma? Ann Endocrinol (Paris). 2025 Jul;86(4):101734. doi: 1016/j.ando.2025.101734. Epub 2025 May 6. PMID: 40409200. Voir fichier : Schubert2025-aggressive-thyroid.pdf